| Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2012: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2011: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2010: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
|---|
| Research Abstract |
DAO activities in the patients having GI toxicity significantly decreased on day 7 (p<0.01), and recovered to the level of pre-chemotherapy on day 28. In contrast, DAO activities in patients without GI toxicity did not change during chemotherapy. Serum DAO activity may be a sensitive biomarker of GI toxicity, and be useful to predict the risk of GI toxicity in esophageal cancer patients during chemotherapy.Enteral supplementation (GFO) is useful for preventing gastrointestinal toxicity during chemotherapy in patients with esophageal carcinoma.
|
